A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies

Autor: HyunSuk Cho, Jacqueline Saleh, Sambasiva P. Rao, Partha S. Chowdhury, Joern Hopke, Samuel D. Stimple, Helene Simonds-Mannes, Jose Sancho, Xiaocong Yu, Ekaterina Boudanova, Ningning Zhang, Ruijun Zhang, Dietmar Hoffmann, Anna Park, Ponraj Prabakaran, Brian C. Mackness
Rok vydání: 2021
Předmět:
Genetically modified mouse
Phage display
Immunology
Mammalian expression
Mice
Transgenic

Cell Separation
Computational biology
Cell Line
Workflow
Immunoglobulin Fab Fragments
03 medical and health sciences
overlapping PCR
0302 clinical medicine
Plasmid
Antibody Specificity
Peptide Library
Report
Animals
Humans
Immunology and Allergy
Selection (genetic algorithm)
single B-cell cloning (SBC)
030304 developmental biology
B-Lymphocytes
0303 health sciences
biology
Antibodies
Monoclonal

Flow Cytometry
High-Throughput Screening Assays
transgenic mouse
functional screening
Immunoglobulin G
030220 oncology & carcinogenesis
biology.protein
Hybridoma technology
monoclonal antibody (mAb)
phage display
Antibody
Cell Surface Display Techniques
linear expression cassettes (LECs)
Spleen
Function (biology)
Antibody discovery
Zdroj: mAbs
article-version (VoR) Version of Record
ISSN: 1942-0870
1942-0862
DOI: 10.1080/19420862.2021.1904546
Popis: Hybridoma technology has been valuable in the development of therapeutic antibodies. More recently, antigen-specific B-cell selection and display technologies are also gaining importance. A major limitation of these approaches used for antibody discovery is the extensive process of cloning and expression involved in transitioning from antibody identification to validating the function, which compromises the throughput of antibody discovery. In this study, we describe a process to identify and rapidly re-format and express antibodies for functional characterization. We used two different approaches to isolate antibodies to five different targets: 1) flow cytometry to identify antigen-specific single B cells from the spleen of immunized human immunoglobulin transgenic mice; and 2) panning of phage libraries. PCR amplification allowed recovery of paired VH and VL sequences from 79% to 96% of antigen-specific B cells. All cognate VH and VL transcripts were formatted into transcription and translation compatible linear DNA expression cassettes (LEC) encoding whole IgG or Fab. Between 92% and 100% of paired VH and VL transcripts could be converted to LECs, and nearly 100% of them expressed as antibodies when transfected into Expi293F cells. The concentration of IgG in the cell culture supernatants ranged from 0.05 µg/ml to 145.8 µg/ml (mean = 18.4 µg/ml). Antigen-specific binding was displayed by 78–100% of antibodies. High throughput functional screening allowed the rapid identification of several functional antibodies. In summary, we describe a plasmid-free system for cloning and expressing antibodies isolated by different approaches, in any format of choice for deep functional screening that can be applied in any research setting during antibody discovery.
Databáze: OpenAIRE